Campoy Carlos 4
4 · CytomX Therapeutics, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Campoy Carlos
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-16$1.98/sh−1,748$3,459→ 38,224 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
- [F2]Includes 16,875 restricted stock units.